9:22 AM
Leo Group India
| ||
| Sun Pharma's Caraco gets USFDA nod to resume drug production Economic Times NEW DELHI: Sun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subsidiary, Caraco for two drugs after inspections of facilities early this year. Subsequent to ... See all stories on this topic » | ||
| Special Report: China's "wild east" drug store Reuters SHANGHAI/LONDON (Reuters) - Philippe Andre, a detective in the murky world of Chinese pharmaceuticals, has some alarming tales to tell. In May last year, he visited a factory an hour outside Shanghai that supposedly produced a pharmaceutical ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners, Inc. Raises $6 Million in Registered Direct ... Equities.com 28, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has entered into definitive agreements to sell (i) 4.0 million shares of the Company's common stock, and (ii) common stock purchase warrants to ... See all stories on this topic » | ||
| 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year Seeking Alpha 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year. August 28, 2012 by: Markus Aarnio | includes: ALXA, GENT, HZNP, SCMP, SVNT. Pharmaceutical companies very often have a run-up leading into drug approval dates. I usually try to buy ... See all stories on this topic » | ||
| Reckitt climbs as analysts say its pharma business could be worth up to £5bn ... The Guardian (blog) Reckitt Benckiser's pharmaceutical business could be worth up to £5bn if it were sold off, according to analysts at Morgan Stanley, despite competition worries surrounding its suboxone heroin substitute. The company, best known for its Cillit Bang and ... See all stories on this topic » | ||
| Cipla plans to shift headquarters, keen on buying Rs 270 crore space in ... Economic Times MUMBAI: Pharmaceutical major Cipla is close to buying office space in central Mumbai, in a deal worth over Rs 270 crore, three people familiar with the development said. The office space under consideration - about 1.30 lakh sq ft at Peninsula Business ... See all stories on this topic » | ||
| REXAHN PHARMACEUTICALS, INC. : Rexahn Pharmaceuticals Announces ... 4-traders Rockville, MD, August 28, 2012 - Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II ... See all stories on this topic » | ||
| Watson Pharmaceuticals Is A Buy Seeking Alpha Watson Pharmaceuticals Inc. (WPI) is one of my 10/10/10 stocks. My philosophy is that the only way to have a portfolio that will return in excess of 10% is to only buy stocks that are projected to have a 10% increase in Revenue, Earnings and Total Return. See all stories on this topic » | ||
| The Pharmaceutical Market: China The Herald | HeraldOnline.com Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The ... See all stories on this topic » | ||
| Pascal Soriot Appointed Chief Executive Officer of AstraZeneca Pharmaceutical Processing A French national, 53 year old Pascal Soriot joins AstraZeneca from Roche AG where he has served as Chief Operating Officer of the company's pharmaceuticals division since 2010. In his current role he has global responsibility for development, ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment